Clinical pharmacological study of [11C]S-dThd reflecting DNA synthesis rate
Not Applicable
- Conditions
- Cancer
- Registration Number
- JPRN-UMIN000004319
- Lead Sponsor
- ational Institute of Radiological Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
- Severe heart disease (≥ NYHA class II) - Severe renal dysfunction - Performance Status (PS)≥2; intolerable to PET scanning - Lack in ability to give an informed consent - Patients regarded as unsuitable by responsible investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety, pharmacokinetics, exposure dose, and tumor accumulation
- Secondary Outcome Measures
Name Time Method